Evidence map›Paper›PMID 34640500›Full record

ArticleJournal of clinical medicine2021

Circulating Tumor Cells and TWIST Expression in Patients with Metastatic Gastric Cancer: A Preliminary Study.

Joon Hyung Jhi, Gwang Ha Kim, Su Jin Park, Dong Uk Kim, Moon Won Lee, Bong Eun Lee, Chae Hwa Kwon, Yoon-Kyoung Cho

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Joon Hyung JhiDepartment of Internal Medicine, Pusan National University College of Medicine, Busan 49241, Korea.
Gwang Ha KimDepartment of Internal Medicine, Pusan National University College of Medicine, Busan 49241, Korea.ORCID 0000-0001-9721-5734
Su Jin ParkBiomedical Research Institute, Pusan National University Hospital, Busan 49241, Korea.
Dong Uk KimDepartment of Internal Medicine, Pusan National University College of Medicine, Busan 49241, Korea.
Moon Won LeeDepartment of Internal Medicine, Pusan National University College of Medicine, Busan 49241, Korea.
Bong Eun LeeDepartment of Internal Medicine, Pusan National University College of Medicine, Busan 49241, Korea.
Chae Hwa KwonBiomedical Research Institute, Pusan National University Hospital, Busan 49241, Korea.
Yoon-Kyoung ChoDepartment of Biomedical Engineering, Ulsan National Institute of Science and Technology (UNIST), Ulsan 44919, Korea.ORCID 0000-0001-6423-1834
Pusan National University · KRPusan National University Hospital · KRInstitute for Basic Science · KR

Funding

the Ministry for Health & Welfare, Republic of Korea HI19C0521
6 · The paper itself

Abstract

BACKGROUND AND

aimsThe clinical significance of circulating tumor cells (CTCs) and TWIST expression in CTCs remains unelucidated in patients with gastric cancer (GC). Here, we evaluated CTCs and TWIST expression in CTCs and explored their correlation with prognosis in patients with metastatic GC.

methodsPeripheral blood samples were prospectively obtained from 31 patients with metastatic GC between September 2017 and December 2018, prior to treatment. CTCs were detected using a centrifugal microfluidic system and CTCs positive for TWIST immunostaining were defined as TWIST (+) CTCs.

resultsCTCs and TWIST (+) CTCs were detected in 25 (80.6%) and 24 (77.4%) of the 31 patients, respectively. CTC count in patients with first diagnosis of metastatic cancer tended to be higher than that in those with recurrent metastatic cancer, but TWIST (+) CTC count was not different between the two groups. There was no difference in CTC and TWIST (+) CTC counts according to histopathologic type, peritoneal dissemination, hematogenous metastasis, serum tumor makers, or response to first-line chemotherapy. Patients with CTCs > 7.5/7.5 mL of blood showed shorter overall survival (OS) than those with CTCs ≤ 7.5/7.5 mL of blood (

conclusionsOur study demonstrated that high levels of CTCs and TWIST (+) CTCs were associated with worse OS.

Indexed as

circulating tumor cellsprognosisstomach neoplasmsTWIST

Identifiers

PMID34640500
PMCPMC8509658
OpenAlexW3202359529

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.